Welcome : Guest

Impax Laboratories, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Impax Laboratories, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 25 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64623
Price: $1250
Company Type: Public
Pages: 28
Date: November 2016
Market Data Tables: 25

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Impax Laboratories, Inc.’s Sales by Business Segment (2014-2015) in Percentage for Impax Generics, and Impax Specialty Pharma......3
Table 2: Impax Laboratories, Inc.’s Sales by Business Segment (2013-2014) in Percentage for Global Division and Impax Division......4
Generic Drugs......6
Table 3: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......6
Table 4: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......7
Central Nervous System (CNS)......8
Table 5: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......8
Parkinson's......9
Table 6: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......9
Table 7: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......10
Generic Pharmaceuticals......11
Table 8: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......11
Table 9: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others......12
Table 10: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......13
Table 11: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......14
Table 12: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......15
Table 13: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......16
Table 14: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......17
Table 15: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......18
Table 16: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. and GlaxoSmithKline......19
Table 17: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......20
Table 18: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......21
Table 19: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......22
IV Generic Drugs......23
Table 20: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......23
Generic Lidoderm......24
Table 21: Market Shares of Leading Generic Lidoderm Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Actavis plc, Endo International plc authorized Generic, Mylan N.V., and Other Generics......24
Generic Percocet......25
Table 22: Market Shares of Leading Generic Percocet Manufacturers in the US (2015) - Percentage Breakdown by Value for Actavis Plc, Mallinckrodt Pharmaceuticals, and Others......25
Generic Vicodin......26
Table 23: Market Shares of Leading Generic Vicodin Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis Plc, Mallinckrodt, and Others......26
Central Nervous System (CNS) Medicine......27
Table 24: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......27
Table 25: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......28